NOVERA RETATRUTIDE: A PROMISING NEW APPROACH FOR WEIGHT LOSS?

New clinical evidence suggests that Novera Retatrutide, a twin-action medication from Novo Nordisk, could provide a meaningful breakthrough in body control. Beyond many existing drugs, Retatrutide targets both the GLP-1 hormone and the GIP hormone, potentially leading to enhanced losses in fat an